Literature DB >> 32075408

Current Treatment Options for Intervertebral Disc Pathologies.

Stephen M Eisenstein1,2, Birender Balain1, Sally Roberts1,2.   

Abstract

The complex structure of the intervertebral disc within the spine is well suited to its mechanical function. However, it is also prone to degeneration, which is associated with various clinical symptoms and conditions, ranging from disc herniation to back pain to spinal stenosis. Most patients' conditions are managed conservatively but a small proportion progress to having surgery. This may be decompression (to remove tissue such as the disc, bone, or hypertrophic ligaments impinging on nerves) or fusion of the normally mobile intervertebral joint to immobilize it and so reduce pain. These used to involve fairly major surgical procedures, but in the past decade there has been much progress to make the surgery more refined and less invasive, for example using endoscopic approaches. Simultaneously, the research world has been studying and developing tissue engineering and cellular techniques for attempting to regenerate the intervertebral disc, whether simply the central nucleus pulposus or a complete intricate assembly to replicate the native structure of this and the surrounding annulus fibrosus, cartilage endplate, and bone. To date, none of the complex entities have been trialed, while cellular approaches are easier to utilize, have progressed to clinical trials, and may offer a better solution.

Entities:  

Keywords:  back pain; cell therapy; intervertebral disc degeneration; surgery

Mesh:

Year:  2020        PMID: 32075408      PMCID: PMC7097980          DOI: 10.1177/1947603520907665

Source DB:  PubMed          Journal:  Cartilage        ISSN: 1947-6035            Impact factor:   4.634


  45 in total

1.  Predictors of inpatient morbidity and mortality in adult spinal deformity surgery.

Authors:  Nancy Worley; Bryan Marascalchi; Cyrus M Jalai; Sun Yang; Bassel Diebo; Shaleen Vira; Anthony Boniello; Virginie Lafage; Peter G Passias
Journal:  Eur Spine J       Date:  2015-07-09       Impact factor: 3.134

2.  Is Osteogenic Differentiation of Human Nucleus Pulposus Cells a Possibility for Biological Spinal Fusion?

Authors:  Sharon J Brown; Sarah A Turner; Birender S Balain; Neil T Davidson; Sally Roberts
Journal:  Cartilage       Date:  2018-01-23       Impact factor: 4.634

3.  Long-term outcomes of surgical and nonsurgical management of lumbar spinal stenosis: 8 to 10 year results from the maine lumbar spine study.

Authors:  Steven J Atlas; Robert B Keller; Yen A Wu; Richard A Deyo; Daniel E Singer
Journal:  Spine (Phila Pa 1976)       Date:  2005-04-15       Impact factor: 3.468

Review 4.  Histology and pathology of the human intervertebral disc.

Authors:  Sally Roberts; Helena Evans; Jayesh Trivedi; Janis Menage
Journal:  J Bone Joint Surg Am       Date:  2006-04       Impact factor: 5.284

Review 5.  Mechanical design criteria for intervertebral disc tissue engineering.

Authors:  Nandan L Nerurkar; Dawn M Elliott; Robert L Mauck
Journal:  J Biomech       Date:  2010-01-18       Impact factor: 2.712

6.  Survival and clinical outcome of SB Charite III disc replacement for back pain.

Authors:  R Ross; A H Mirza; H E Norris; M Khatri
Journal:  J Bone Joint Surg Br       Date:  2007-06

7.  Exhaustion of nucleus pulposus progenitor cells with ageing and degeneration of the intervertebral disc.

Authors:  Daisuke Sakai; Yoshihiko Nakamura; Tomoko Nakai; Taishi Mishima; Shunichi Kato; Sibylle Grad; Mauro Alini; Makarand V Risbud; Danny Chan; Kathryn S E Cheah; Ken-ichi Yamamura; Koichi Masuda; Hideyuki Okano; Kiyoshi Ando; Joji Mochida
Journal:  Nat Commun       Date:  2012       Impact factor: 14.919

Review 8.  Cell therapy for intervertebral disc repair: Clinical perspective.

Authors:  Daisuke Sakai; Jordy Schol
Journal:  J Orthop Translat       Date:  2017-02-23       Impact factor: 5.191

9.  Autologous mesenchymal stromal cells embedded in tricalcium phosphate for posterolateral spinal fusion: results of a prospective phase I/II clinical trial with long-term follow-up.

Authors:  Juan F Blanco; Eva M Villarón; David Pescador; Carmen da Casa; Victoria Gómez; Alba M Redondo; Olga López-Villar; Miriam López-Parra; Sandra Muntión; Fermín Sánchez-Guijo
Journal:  Stem Cell Res Ther       Date:  2019-02-22       Impact factor: 6.832

10.  Viability, growth kinetics and stem cell markers of single and clustered cells in human intervertebral discs: implications for regenerative therapies.

Authors:  Sarah Turner; Birender Balain; Bruce Caterson; Clare Morgan; Sally Roberts
Journal:  Eur Spine J       Date:  2014-08-06       Impact factor: 3.134

View more
  6 in total

Review 1.  NF-κB signalling pathways in nucleus pulposus cell function and intervertebral disc degeneration.

Authors:  Guang-Zhi Zhang; Ming-Qiang Liu; Hai-Wei Chen; Zuo-Long Wu; Yi-Cheng Gao; Zhan-Jun Ma; Xue-Gang He; Xue-Wen Kang
Journal:  Cell Prolif       Date:  2021-05-24       Impact factor: 6.831

Review 2.  Spheroid-Based Tissue Engineering Strategies for Regeneration of the Intervertebral Disc.

Authors:  Jesil Kasamkattil; Anna Gryadunova; Ivan Martin; Andrea Barbero; Stefan Schären; Olga Krupkova; Arne Mehrkens
Journal:  Int J Mol Sci       Date:  2022-02-25       Impact factor: 6.208

Review 3.  Targeting Autophagy for Developing New Therapeutic Strategy in Intervertebral Disc Degeneration.

Authors:  Md Entaz Bahar; Jin Seok Hwang; Mahmoud Ahmed; Trang Huyen Lai; Trang Minh Pham; Omar Elashkar; Kazi-Marjahan Akter; Dong-Hee Kim; Jinsung Yang; Deok Ryong Kim
Journal:  Antioxidants (Basel)       Date:  2022-08-14

4.  Ion elemental-optimized layered double hydroxide nanoparticles promote chondrogenic differentiation and intervertebral disc regeneration of mesenchymal stem cells through focal adhesion signaling pathway.

Authors:  Zhaojie Wang; Huiyi Yang; Xu Xu; Hongxing Hu; Yuxin Bai; Jian Hai; Liming Cheng; Rongrong Zhu
Journal:  Bioact Mater       Date:  2022-09-26

Review 5.  Intervertebral Disk Degeneration: The Microenvironment and Tissue Engineering Strategies.

Authors:  Yiming Dou; Xun Sun; Xinlong Ma; Xin Zhao; Qiang Yang
Journal:  Front Bioeng Biotechnol       Date:  2021-07-20

6.  High hydrostatic pressure (30 atm) enhances the apoptosis and inhibits the proteoglycan synthesis and extracellular matrix level of human nucleus pulposus cells via promoting the Wnt/β-catenin pathway.

Authors:  Zongting Shi; Jun He; Jian He; Yuan Xu
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.